Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)

[1] Seaton RA(2014)Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals Eur J Clin Microbiol Infect Dis 33 305-311

[2] Johal S(2009)Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom J Antimicrob Chemother 63 849-861

[3] Coia JE(2010)A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice Clin Microbiol Infect 16 3-30

[4] Gould FK(2011)Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections Int J Antimicrob Agents 38 243-248

[5] Brindle R(2012)Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement J Antimicrob Chemother 67 1053-1062

[6] Chadwick PR(2001)Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia Am J Med 111 412-413

[7] Dryden M(2004)Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come Eur J Clin Microbiol Infect Dis 23 78-81

[8] Andrasevic AT(2005)Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy Clin Microbiol Infect 11 33-42

[9] Bassetti M(2014)Cephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited J Chemother 26 65-66

[10] Seaton RA(1998)Factors in antibiotic selection for hospital formularies (part I) Hosp Formul 33 558-572

[1] Seaton RA(2014)Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals Eur J Clin Microbiol Infect Dis 33 305-311

[2] Johal S(2009)Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom J Antimicrob Chemother 63 849-861

[3] Coia JE(2010)A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice Clin Microbiol Infect 16 3-30

[4] Gould FK(2011)Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections Int J Antimicrob Agents 38 243-248

[5] Brindle R(2012)Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement J Antimicrob Chemother 67 1053-1062

[6] Chadwick PR(2001)Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia Am J Med 111 412-413

[7] Dryden M(2004)Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come Eur J Clin Microbiol Infect Dis 23 78-81

[8] Andrasevic AT(2005)Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy Clin Microbiol Infect 11 33-42

[9] Bassetti M(2014)Cephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited J Chemother 26 65-66

[10] Seaton RA(1998)Factors in antibiotic selection for hospital formularies (part I) Hosp Formul 33 558-572